Vitamin K Administration Guidelines

Primary Clinical Indications

All newborns should receive vitamin K at birth to prevent vitamin K deficiency bleeding (VKDB), which can cause devastating intracranial hemorrhage and death, according to the American Academy of Pediatrics 1
Newborns have physiologically low levels of vitamin K-dependent clotting factors compared to adults, making them inherently vulnerable to bleeding disorders 1
Exclusively breastfed infants are at particularly high risk of VKDB because breast milk contains very low concentrations of vitamin K 1
For warfarin-associated intracranial hemorrhage, vitamin K 10 mg IV should be administered immediately along with prothrombin complex concentrates to ensure durable INR reversal, as recommended by the American College of Chest Physicians 2

Deficiency results in prolonged prothrombin time with impaired clotting or frank bleeding, confirmed by response to vitamin K administration, with a strength of evidence rated as high 3, 6, 4
Beyond hemostasis, vitamin K deficiency contributes to poor bone development, osteoporosis, and increased cardiovascular disease risk, with a moderate strength of evidence 6, 4

IV administration should be by slow injection to minimize risk of rare anaphylactoid reactions (3 per 100,000 doses) that can cause bronchospasm and cardiac arrest, as warned by the FDA 5
Never exceed 10 mg per dose, as higher doses can create a prothrombotic state and prevent re-anticoagulation for days, according to the American College of Cardiology 5
Patients on anti-vitamin K drugs should avoid sudden major changes in vitamin K intake and require monitoring with blood clotting tests, as recommended by the National Institutes of Health 3, 4

Avoid vitamin K reversal when intracranial hemorrhage is suspected due to cerebral venous thrombosis, as reversal may worsen thrombosis, with a high strength of evidence 2
In liver disease without cholestasis, vitamin K has minimal efficacy because the liver cannot synthesize clotting factors despite adequate vitamin K, according to the American Association for the Study of Liver Diseases 5